| 000 | 01840 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513202014.0 | ||
| 264 | 0 | _c20000224 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0167-0115 | ||
| 024 | 7 |
_a10.1016/s0167-0115(99)00080-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEkblad, E | |
| 245 | 0 | 0 |
_aPharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon. _h[electronic resource] |
| 260 |
_bRegulatory peptides _cDec 1999 |
||
| 300 |
_a87-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApamin _xpharmacology |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIndazoles _xpharmacology |
| 650 | 0 | 4 |
_aMuscle Relaxation _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
| 650 | 0 | 4 |
_aMyenteric Plexus _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNeuropeptides _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 650 | 0 | 4 | _aPituitary Adenylate Cyclase-Activating Polypeptide |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide |
| 650 | 0 | 4 | _aReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I |
| 650 | 0 | 4 |
_aReceptors, Pituitary Hormone _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Vasoactive Intestinal Peptide _xdrug effects |
| 650 | 0 | 4 |
_aTetrodotoxin _xpharmacology |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
| 773 | 0 |
_tRegulatory peptides _gvol. 85 _gno. 2-3 _gp. 87-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0167-0115(99)00080-4 _zAvailable from publisher's website |
| 999 |
_c10606096 _d10606096 |
||